Cargando…
Prognostic Factors and Therapeutic Outcomes in 22 Patients with Pleomorphic Xanthoastrocytoma
OBJECTIVE: Pleomorphic xanthoastrocytoma (PXA) is a rare primary low-grade astrocytic tumor classified as WHO II. It is generally benign, but disease progression and malignant transformation have been reported. Prognostic factors for PXA and optimal therapies are not well known. METHODS: The study p...
Autores principales: | Lim, Sungryong, Kim, Jeong Hoon, Kim, Sun A, Park, Eun Suk, Ra, Young Shin, Kim, Chang Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Neurosurgical Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730029/ https://www.ncbi.nlm.nih.gov/pubmed/23908701 http://dx.doi.org/10.3340/jkns.2013.53.5.281 |
Ejemplares similares
-
A case series of pediatric survivors of anaplastic pleomorphic xanthoastrocytoma
por: Ronsley, Rebecca, et al.
Publicado: (2021) -
Pleomorphic xanthoastrocytoma: a brief review
por: Shaikh, Nawal, et al.
Publicado: (2019) -
Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience
por: Sullivan, Jared, et al.
Publicado: (2023) -
BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma
por: Migliorini, Denis, et al.
Publicado: (2017) -
Pleomorphic xanthoastrocytoma in a case of tuberous sclerosis
por: Martin, Arvind G., et al.
Publicado: (2014)